Results 51 to 60 of about 5,401 (225)
Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema [PDF]
INTRODUCTION: Pimecrolimus , a calcineurin inhibitor, is a non-steroidal treatment option in patients aged ≥ 2 years with mild-to-moderate atopic eczema (AE).
Prucha, Hanna +13 more
core +2 more sources
Atopic dermatitis (AtD) is multifactorial inflammatory skin disease with high prevalence in pediatric population. It is crucial to implement long-term maintenance therapy to prevent AtD exacerbations according to current clinical guidelines and expert ...
Nikolay N. Murashkin +6 more
doaj +1 more source
Skin samples of Hailey‐Hailey and Darier diseases were analyzed for inflammatory and barrier markers using indirect immunofluorescence and transcriptomic techniques. A mixed Th2/Th17 inflammatory pattern and altered expression of barrier markers were observed.
Ella Glodjajic +10 more
wiley +1 more source
ABSTRACT Dupilumab‐associated erythema multiforme and lichenoid eruptions have been previously reported as rare dermatological adverse events. We present an atypical paediatric case of a dupilumab‐associated erythema multiforme‐like eruption in a 5‐year‐old male eczema patient, who developed erythematous targetoid papules and plaques over the upper and
Paul Sun Woo Kim +7 more
wiley +1 more source
Analysis of pruritus (pimecrolimus vs tacrolimus).
Analysis of pruritus (pimecrolimus vs tacrolimus).
Youyu Sheng (545451) +1 more
core +1 more source
Topical treatment of atopic dermatitis in children: current challenges and answers
Atopic dermatitis (AD) is the most prevalent skin disease in the early childhood and is a considerable problem both for patients and members of their families and for the society on the whole.
L. S. Namazova-Baranova +4 more
doaj +1 more source
Dupilumab in Paediatric Netherton Syndrome: Two Case Reports and a Review of the Literature
ABSTRACT Netherton Syndrome (NS) is a rare genodermatosis characterised by a triad of ichthyosiform erythroderma, an atopic diathesis, and trichorrhexis invaginata, for which no effective management is currently approved in Australia. Dupilumab has demonstrated considerable effectiveness in the treatment of atopic conditions in the paediatric ...
Jacqueline Tu +5 more
wiley +1 more source
Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus.
Using a newly developed model of allergic contact dermatitis in pigs, calcineurin inhibitors of the tacrolimus and ascomycin type were shown to have a highly anti-inflammatory action after topical application.
Meingassner, Josef +4 more
core +1 more source
Inicialmente, denominada "Balanoposthite chronique circonscrite benigne a plasmocytes", a balanite plasmocitária de Zoon é uma dermatose inflamatória crônica da glande e prepúcio afetando homens não circuncisados.
Livia Delgado +5 more
doaj +1 more source
<i>Aim:</i> To evaluate the systemic exposure of pimecrolimus cream 1% applied under occlusion in atopic dermatitis (AD) patients. <i>Methods:</i> A noncomparative, open-label study conducted in 3 groups of moderate to severe AD ...
Diamant Thaçi +6 more
core +1 more source

